Victrex plc Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 12/6/2025)
| Balance Sheet | Total Assets | 566,900,000.00 | ROE | 76.47 % |
| Balance Sheet | Total Equity | 433,500,000.00 | ROA | 4.90 % |
| Cashflow | Capital Expenditures | -21,800,000.00 | P/FCF | 16.58 |
| Cashflow | Free Cash Flow | 49,300,000.00 | – | – |
| Cashflow | Operating Cash Flow | 71,100,000.00 | P/CF | 11.50 |
| Income | Earnings per Share (diluted) | 2.80 | Div. Yield | 6.33 % |
| Income | Net Income | 27,800,000.00 | P/E | 29.13 |
| Income | Shares Outstanding | 87,052,100.00 | P/B | 1.89 |
| Income | Total Revenue | 292,700,000.00 | P/S | 2.76 |
Ratios calculated on: 10/14/2026
Company Description
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It offers PEEK and PAEK polymer materials; and specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.victrexplc.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more